Psychoactive Substances

Podcast: Expert Talks About 'Kanna,' The Legal African Succulent That Elevates Awareness, Concentration And More
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds
'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges
Lucy Scientific Gears Up For Global Wellness Via Acquisition, On Heels Of High Times News

Psychoactive Substances Recent News

Amanita Muscaria Mushrooms Are Taking The Lead In Markets As Research Ramps Up
Amanita Muscaria is the only kind of mushroom currently legal. As its health benefits are regularly being confirmed in studies, demand for related products is rapidly growing.
FSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive Disorder
Biotech company FSD Pharma Inc. (NASDAQ: HUGE)’s Australian business FSD Pharma Australia Pty Ltd. has been approved by the Alfred Ethics Committee to begin a Phase 1 clinical trial of next-gen drug candidate Lucid-201, or Lucid-Psych, for cases of Major Depressive Disorder (MDD.) 
High Times And Lucy Scientific Discovery Launching Amanita Muscaria Mushrooms Product
Psychedelics producer Lucy Scientific Discovery Inc. (NASDAQ: LSDI) is launching a new brand of products containing unscheduled psychoactive compounds, soon available for sale in the U.S. and all other parts of the world where legal.
Psychedelics & Environmental Protection: Company Seeks Patents To Synthetically Produce Toad Venom
Psychedelic therapeutics biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed three additional U.S.
Psychedelics & Role Of Memory In Healing Process, New Trial Led By Univ. Of Wisconsin
The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances (TCRPS) was created to foster education and research on the field of medical applications of psychedelics, and one of them is specifically studying if remembering the psychedelic-induced hallucinations is a fundamental part of these substances' therapeutic effects.